Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 34,350
-2,700 (-7.29%)
At close: Jul 28, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 284.32 billion as of July 28, 2026. Its market cap has decreased by -38.94% in one year.
Market Cap
284.32B
Enterprise Value
258.15B
Revenue
16.82B
Ranking
n/a
PE Ratio
n/a
Stock Price
34,350.00
ChartMarket Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 284.32B, an increase of 49.81%. That is a compound annual growth rate of 23.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 284.32B | -61.23% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 210.34B |
| MEDIANA Co.,Ltd | 179.90B |
| Mezoo | 125.70B |
| L&K Biomed | 89.18B |
| Remed | 84.38B |
| Dynamic solution | 70.08B |
| SELVAS Healthcare | 66.74B |
| Hironic | 56.25B |